0001562180-15-000467.txt : 20150608
0001562180-15-000467.hdr.sgml : 20150608
20150608134407
ACCESSION NUMBER: 0001562180-15-000467
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150608
FILED AS OF DATE: 20150608
DATE AS OF CHANGE: 20150608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anderson Thomas
CENTRAL INDEX KEY: 0001612903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 15918087
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-06-08
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001612903
Anderson Thomas
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
See Remarks
Common Stock
2015-06-08
4
M
false
5500.00
8.92
A
11500.00
D
Common Stock
2015-06-08
4
S
false
4300.00
79.95
D
7200.00
D
Common Stock
2015-06-08
4
S
false
1200.00
78.56
D
6000.00
D
Stock Options (Right to buy)
8.92
2015-06-08
4
M
false
5500.00
0.00
D
2024-05-21
Common Stock
5500.00
132169.00
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This transaction was executed in multiple trades at prices ranging from $79.15 USD to $80.09 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $78.26 USD to $78.96 USD. The price reported above reflects the weighted average sale price.
The option, representing a right to purchase a total of 137,669 shares, became partially exercisable beginning on May 05, 2015. 25% of this option vested on May 05, 2015 and the remainder vests in equal monthly installments thereafter over 36 months.
/s/ Laurie Burlingame, as Attorney-in-Fact for Thomas Anderson
2015-06-08